Pommier Y, Capranico G, Orr A, Kohn K W
Laboratory of Molecular Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
J Mol Biol. 1991 Dec 20;222(4):909-24. doi: 10.1016/0022-2836(91)90585-t.
The distributions of DNA cleavage sites induced by topoisomerase II in the presence or absence of specific drugs were mapped in the simian virus 40 genome. The drugs studied were 5-iminodaunorubicin, amsacrine (m-AMSA), teniposide (VM-26) and 2-methyl-9-hydroxyellipticinium; each produced a distinctive pattern of enhanced cleavage. Consistently intense cleavage, both in the presence and in the absence of drugs, occurred in the nuclear matrix-associated region. Since topoisomerase II is a major constituent of the nuclear matrix, and cleavage complexes include a covalent link between topoisomerase II and DNA, the findings suggest that topoisomerase II may function to attach DNA to the nuclear matrix. Cleavage usually occurred on both DNA strands with the expected four base-pair 5' stagger, and strong sites tended to occur within A/T runs such as have been associated with binding to the nuclear scaffold. Intense cleavage was present also in the replication termination region, but was absent from the vicinity of the replication origin. Cleavage intensities were found to change with time in a manner that depended both on the site and on the drug, suggesting that topoisomerase II can move along the DNA from a kinetically preferred site to a thermodynamically preferred site.
在猿猴病毒40基因组中绘制了拓扑异构酶II在存在或不存在特定药物的情况下诱导的DNA切割位点分布。所研究的药物有5-亚氨基柔红霉素、安吖啶(m-AMSA)、替尼泊苷(VM-26)和2-甲基-9-羟基玫瑰树碱;每种药物都产生了独特的增强切割模式。无论有无药物,在核基质相关区域均出现持续强烈的切割。由于拓扑异构酶II是核基质的主要成分,且切割复合物包括拓扑异构酶II与DNA之间的共价连接,这些发现表明拓扑异构酶II可能起到将DNA附着于核基质的作用。切割通常发生在两条DNA链上,具有预期的四个碱基对的5'交错,且强切割位点倾向于出现在与核支架结合相关的A/T序列内。复制终止区域也存在强烈切割,但复制起点附近没有。发现切割强度随时间变化,其方式既取决于位点也取决于药物,这表明拓扑异构酶II可以沿着DNA从动力学上优先的位点移动到热力学上优先的位点。